Aptima Herpes Simplex Viruses 1 & 2 Assay
K162673 is the FDA 510(k) clearance record for Aptima Herpes Simplex Viruses 1 & 2 Assay, a class II device, cleared for Hologic, Inc. on under FDA product code OQO (Herpes Simplex Virus Nucleic Acid Amplification Assay). FDA's definition for product code OQO reads: "A polymerase chain reaction (pcr)-based qualitative in vitro diagnostic test for the detection and typing of herpes simplex virus (hsv) dna using vaginal swab specimens". FDA records list 189 510(k) clearances for Hologic, Inc., from to . As of , FDA records show no recalls naming K162673.
Clearance record
- Decision date
- Received
- (262 days to decision)
- Product code
- OQO Herpes Simplex Virus Nucleic Acid Amplification Assay
- Regulation
- 21 CFR 866.3305
- Device class
- Class II
- Review panel
- Microbiology
- Applicant
- Hologic, Inc. 10210 Genetic Center Dr., San Diego CA
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code OQO
Trailing 12 monthsFDA records hold no clearances under product code OQO in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
